ARHGAP5 and gastric cancer: In addition, lncRNA Rho GTPase activating protein 5 (ARHGAP5)-AS1 recruited METTL3 to enhance the stability of ARHGAP5 mRNA, eventually leading to the poor prognosis and chemoresistance of GC [41].